BIOMAT Database Logo BIOMAT Database Logo

[Myasthenic syndrome during treatment with D penicillamine. A recent case]. 1977

J M Verret, and N Lignac, and M F Kahn

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

J M Verret, and N Lignac, and M F Kahn
[Myasthenic syndrome during penicillamine treatment (author's transl)].
February 1978, Klinische Wochenschrift,
J M Verret, and N Lignac, and M F Kahn
[Myasthenic syndrome--complication of D-penicillamine therapy].
January 1984, Zeitschrift fur arztliche Fortbildung,
J M Verret, and N Lignac, and M F Kahn
D-penicillamine and the ocular myasthenic syndrome.
October 1981, Annals of ophthalmology,
J M Verret, and N Lignac, and M F Kahn
[Myasthenic syndrome following oral treatment with penicillamine].
January 1978, Bulletin de la Societe belge d'ophtalmologie,
J M Verret, and N Lignac, and M F Kahn
[3 cases of myasthenic syndrome induced by D-penicillamine].
November 1987, Bulletin des societes d'ophtalmologie de France,
J M Verret, and N Lignac, and M F Kahn
[Myasthenic syndrome induced by D-penicillamine. Danger of curarization].
December 1980, La Nouvelle presse medicale,
J M Verret, and N Lignac, and M F Kahn
[Nephrotic syndrome with minimal glomerular lesions during treatment with D-penicillamine].
October 1980, La Nouvelle presse medicale,
J M Verret, and N Lignac, and M F Kahn
[A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
June 1982, Arerugi = [Allergy],
J M Verret, and N Lignac, and M F Kahn
Nephrotic syndrome after treatment with D-penicillamine.
January 1968, Lancet (London, England),
J M Verret, and N Lignac, and M F Kahn
Myasthenic syndrome during treatment with practolol.
July 1976, British medical journal,
Copied contents to your clipboard!